Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2020; 10(14):6261-6277. doi:10.7150/thno.42523 This issue Cite

Review

Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer

Dinoop Ravindran Menon1*, Heinz Hammerlindl2*, Joachim Torrano2, Helmut Schaider2✉, Mayumi Fujita1,3,4✉

1. Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, USA
2. The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, OLD, Australia
3. Eastern Colorado VA Health Care System, Aurora CO, USA
4. Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA
*These authors contributed equally to the study

✉ Corresponding authors: Mayumi Fujita, University of Colorado School of Medicine, 12801 E.17th Ave, MS 8127, RC-1S, Rm L18-4124, Aurora, CO 80045. Phone: 303-724-4045; Fax: 303-724-4048; E-mail: mayumi.fujitaedu. Helmut Schaider, The Univ More

Citation:
Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics 2020; 10(14):6261-6277. doi:10.7150/thno.42523. https://www.thno.org/v10p6261.htm
Other styles

File import instruction

Abstract

Graphic abstract

Despite the recent advances in the treatment of cancers, acquired drug resistance remains a major challenge in cancer management. While earlier studies suggest Darwinian factors driving acquired drug resistance, recent studies point to a more dynamic process involving phenotypic plasticity and tumor heterogeneity in the evolution of acquired drug resistance. Chronic stress after drug treatment induces intrinsic cellular reprogramming and cancer stemness through a slow-cycling persister state, which subsequently drives cancer progression. Both epigenetic and metabolic mechanisms play an important role in this dynamic process. In this review, we discuss how epigenetic and metabolic reprogramming leads to stress-induced phenotypic plasticity and acquired drug resistance, and how the two reprogramming mechanisms crosstalk with each other.

Keywords: Epigenetics, metabolism, stress-induced plasticity, stemness

Citation styles

APA
Ravindran Menon, D., Hammerlindl, H., Torrano, J., Schaider, H., Fujita, M. (2020). Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics, 10(14), 6261-6277. https://doi.org/10.7150/thno.42523.

ACS
Ravindran Menon, D.; Hammerlindl, H.; Torrano, J.; Schaider, H.; Fujita, M. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics 2020, 10 (14), 6261-6277. DOI: 10.7150/thno.42523.

NLM
Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics 2020; 10(14):6261-6277. doi:10.7150/thno.42523. https://www.thno.org/v10p6261.htm

CSE
Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. 2020. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics. 10(14):6261-6277.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use